Bisnorcymserine in Healthy Adult Volunteers

计划入组 75 人 · 首次发布于 2012 年 12 月 11 日

Phase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple Negative Breast Cancer

计划入组 34 人 · 首次发布于 2025 年 6 月 12 日

A Prospective, Multicenter, Phase II Clinical Study of Postoperative Chemotherapy Combined With QL1706 for High-risk Triple-negative Breast Cancer.

计划入组 59 人 · 首次发布于 2026 年 6 月 3 日

TNBC vaccine

TNBC(ProteinQure)

ADXS-TNBC

Lukashenko Proposes Belarus-Russia Biotechnology Collaboration, Highlighting BNBC's Deep Grain Processing Capabilities

Atezolizumab Fails to Improve Event-Free Survival in Triple-Negative Breast Cancer

Tislelizumab Triplet Demonstrates Promising Results in Metastatic TNBC